Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03305770 · ClinicalTrials.gov registry record · NA
DD T2 Daily Disposable Registration Trial
A NA study of Myopia and Refractive Errors, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
- 6
- Study locations
NCT03305770 is a NA study of Myopia and Refractive Errors that has completed, run by Alcon Research. The registered enrollment target is 107 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (60% lower). The trial reports 6 study locations across 4 states.
The verdict
NCT03305770, a NA study of Myopia and Refractive Errors, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to evaluate the performance of the investigational verofilcon A contact lens compared to the commercially available delefilcon A contact lens, by assessing visual acuity as the primary variable.
Conditions Studied
Interventions
- DEVICE verofilcon A contact lenses
- DEVICE delefilcon A contact lenses
Study Locations (6)
Florida
- Alcon Investigative Site - Longwood
- Alcon Investigative Site - Maitland
Tennessee
- Alcon Investigative Site - Brentwood
- Alcon Investigative Site - Memphis
California
- Alcon Investigative Site - San Diego
Illinois
- Alcon Investigative Site - Bloomington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2017-10-12 |
| Est. Completion | 2018-02-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03305770
The ClinicalTrials.gov registry entry for NCT03305770 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (60% lower). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which verofilcon A contact lenses is the first listed.
NCT03305770 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Florida, Tennessee, California.
Frequently Asked Questions
What is clinical trial NCT03305770 about?
NCT03305770 is a clinical study titled "DD T2 Daily Disposable Registration Trial". The purpose of this study is to evaluate the performance of the investigational verofilcon A contact lens compared to the commercially available delefilcon A contact lens, by assessing visual acuity as the primary variable.
What is the current status of trial NCT03305770?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2017-10-12. Estimated completion is 2018-02-21.
What conditions does trial NCT03305770 study?
This clinical trial studies the following conditions: Myopia, Refractive Errors.
What interventions are being tested in trial NCT03305770?
The interventions under investigation include: verofilcon A contact lenses (DEVICE), delefilcon A contact lenses (DEVICE).
Who is sponsoring clinical trial NCT03305770?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03305770 being conducted?
This trial has 6 study locations across California, Florida, Illinois, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.